Daiwa Securities Group Inc. Dbv Technologies S.A. Transaction History

Daiwa Securities Group Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$6.75 - $11.15 $1,269 - $2,096	-188 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$8.57 - $10.72 $488 - $611	57 Added 43.51%	188 $2,000
Q4 2018 Feb 05, 2019	SELL	$5.75 - $21.85 $88,820 - $337,516	-15,447 Reduced 99.16%	131 $1,000
Q3 2018 Nov 01, 2018	SELL	$16.81 - $24.58 $95,195 - $139,196	-5,663 Reduced 26.66%	15,578 $350,000
Q2 2018 Jul 30, 2018	SELL	$18.6 - $24.94 $113,515 - $152,208	-6,103 Reduced 22.32%	21,241 $410,000
Q1 2018 May 02, 2018	BUY	$20.86 - $26.6 $8,719 - $11,118	418 Added 1.55%	27,344 $631,000
Q4 2017 Feb 06, 2018	BUY	$20.9 - $49.36 $562,753 - $1.33 Million	26,926	26,926 $662,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.